Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 67877-511

10 FDA label images from Ascend Laboratories, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 67877-511). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatin 10mg 10s Blister

Atorvastatin 10mg 10s Blister
Packaging label for Atorvastatin Calcium 10 mg film-coated tablets from Ascend Laboratories, LLC. The label shows the proprietary name, dosage strength as 10 mg base, and distributor location in Parsippany, NJ. It includes a barcode and fields for lot number and expiration date.*
FDA Label Image

Atorvastatin 10mg 10s Cart

Atorvastatin 10mg 10s Cart
Atorvastatin Calcium Tablets USP 10 mg film-coated tablets packaging label. The carton indicates it is for in-institution use only, containing 100 tablets (10 x 10 unit-dose). Labeled Rx only and manufactured by Alkem Laboratories Ltd., India, distributed by Ascend Laboratories, LLC.*
FDA Label Image

Atorvastatin 10mg 90s Tab

Atorvastatin 10mg 90s Tab
Label for Atorvastatin Calcium Tablets, USP 10 mg film-coated tablets, packaged as 90 tablets. The label includes the NDC 67877-511-90 and highlights Ascend Laboratories, LLC as the distributor and Alkem Laboratories Ltd. as the manufacturer in India. Storage and dispensing instructions are provided, along with the Rx only designation.*
FDA Label Image

Atorvastatin 20mg 500s Tab

Atorvastatin 20mg 500s Tab
Label for Atorvastatin Calcium Tablets, USP 20 mg film coated tablets. The bottle contains 500 tablets, Rx Only. Manufactured by Alkem Laboratories Ltd., India, and distributed by Ascend Laboratories, LLC. The label includes storage instructions for controlled room temperature and a barcode with NDC 67877-512-05. A red 20 mg strength indicator is displayed prominently in the center.*
FDA Label Image

Atorvastatin 40mg 1000s Tab

Atorvastatin 40mg 1000s Tab
Label for Atorvastatin Calcium Tablets, USP 40 mg film-coated tablets, prescription drug by Ascend Laboratories, LLC. The label notes storage instructions, dosage directions, and warnings. It states the product contains 1000 tablets and lists Alkem Laboratories Ltd., India as manufacturer and Ascend Laboratories, LLC as distributor. The label includes the NDC 67877-513-10 and a barcode.*
FDA Label Image

Atorvastatin 80mg 1000s Tab

Atorvastatin 80mg 1000s Tab
Label for Atorvastatin Calcium Tablets, USP 80 mg film-coated oral tablets. The label shows 1000 tablets per container and is marked Rx Only. Manufactured by Alkem Laboratories Ltd., India, and distributed by Ascend Laboratories, LLC. Includes storage instructions and a barcode.*
FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

Atorvastatin-fig-1 (Atorvastatin Fig 1)
A line graph showing cumulative incidence (%) over time in years, comparing Atorvastatin calcium and placebo groups. The graph displays that the incidence for the Atorvastatin group increases at a slower rate than the placebo group. A hazard ratio (HR) of 0.64 (0.50-0.83) with a p-value of 0.0005 is noted, indicating statistical analysis results.*
FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

Atorvastatin-fig-2 (Atorvastatin Fig 2)
A Kaplan-Meier cumulative hazard graph depicting time to first primary endpoint over four years of follow-up comparing Atorvastatin and placebo groups. The y-axis shows cumulative hazard percentage, and the x-axis shows years of follow-up. The graph includes hazard ratio (HR 0.63) with confidence intervals and a p-value (0.001), illustrating lower cumulative hazard with Atorvastatin versus placebo.*
FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

Atorvastatin-fig-3 (Atorvastatin Fig 3)
A line graph depicting the percentage of subjects experiencing an event over time in years, comparing 10 mg and 80 mg doses of Atorvastatin. The y-axis shows subjects (%) experiencing events, while the x-axis shows time to first major cardiovascular endpoint up to 5 years. Two lines represent Atorvastatin 10 mg (dashed) and 80 mg (solid), with an annotation of hazard ratio (HR) 0.78 and p-value 0.0002.*
FDA Label Image

Atorvastatin-st (Atorvastatin St)

Atorvastatin-st (Atorvastatin St)
Chemical structure of Atorvastatin Calcium is shown, depicting the detailed molecular arrangement including multiple phenyl rings, hydroxyl groups, and calcium ion association with hydration indicated (Ca2+ with 3H2O).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.